Arexvy Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Resp syncytial virus (RSV) vaccine

Indications/Uses

Active immunisation for the prevention of lower resp tract disease caused by RSV in adults ≥60 yr & those 50-59 yr who are at increased risk for RSV disease.

Dosage/Direction for Use

IM 0.5 mL as a single dose, inj preferably in the deltoid muscle.

Contraindications

Hypersensitivity.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.

Regulatory Classification

POM

Presentation/Packing

Form

Arexvy powd for susp for inj 120 mcg/0.5 mL

Packing/Price

1's

Arexvy

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline Biologicals